Back to results
US 6,958,396 B2Granted
8-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake site
AssigneeSolvay Pharmaceuticals GmbH
InventorCornelis Bakker
Life of this patent
Estimating the term…
Abstract
The invention relates to the novel mesylate of a phenylpiperazine derivative of the formula (I). This salt has favorable properties as compared with the free base of this compound.
Claims6
A compound of formula:
A pharmaceutical composition comprising at least one compound of formula:
- and at least one auxiliary substance.
Dependencies are inferred from the claim text.